1383 related articles for article (PubMed ID: 25609010)
1. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
2. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
3. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
6. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
7. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
[TBL] [Abstract][Full Text] [Related]
8. Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
Wang Z; Hu X; Yue J; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e41-2. PubMed ID: 22195914
[No Abstract] [Full Text] [Related]
9. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
[TBL] [Abstract][Full Text] [Related]
10. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
11. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Duong HH; Yung LY
Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
[TBL] [Abstract][Full Text] [Related]
12. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
13. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
Wang J; Yeung BZ; Cui M; Peer CJ; Lu Z; Figg WD; Guillaume Wientjes M; Woo S; Au JL
J Control Release; 2017 Dec; 268():147-158. PubMed ID: 29054369
[TBL] [Abstract][Full Text] [Related]
14. Functional and developmental analysis of the blood-brain barrier in zebrafish.
Jeong JY; Kwon HB; Ahn JC; Kang D; Kwon SH; Park JA; Kim KW
Brain Res Bull; 2008 Mar; 75(5):619-28. PubMed ID: 18355638
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
16. Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).
Kuroda H; Tachikawa M; Yagi Y; Umetsu M; Nurdin A; Miyauchi E; Watanabe M; Uchida Y; Terasaki T
Mol Pharm; 2019 Jan; 16(1):292-304. PubMed ID: 30452273
[TBL] [Abstract][Full Text] [Related]
17. Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system.
Zou D; Wang W; Lei D; Yin Y; Ren P; Chen J; Yin T; Wang B; Wang G; Wang Y
Int J Nanomedicine; 2017; 12():4879-4889. PubMed ID: 28744122
[TBL] [Abstract][Full Text] [Related]
18. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
19. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
20. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL
Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]